Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the European League Against Rheumatism (EULAR) Congress
DUBLIN, Ohio, June 03, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the […]